Adam J. Litterman
Xalud Therapeutics (United States)
ORCID: 0000-0003-3019-9244MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 3 papers. Top paper: “Non-viral precision T cell receptor replacement for personalized cell therapy”.
N/A
281 citations
Kyle Jacoby, Daniela A. Bota, Theresa Hunter, Zheng Pan, Eric Stawiski +49 more
18 citations
Yohei Mikami, Ryan J. McMonigle, Carlos A. Castellanos, Adam K. Wade‐Vallance, Simon K. Zhou +10 more
3 citations
Adam J. Litterman, Harshaan S. Sekhon, Robin Kageyama, Maya M. Arce, Kimberly E. Taylor +6 more